Diphencyprone as a therapeutic option in cutaneous metastasis of melanoma. A single-institution experience
An. bras. dermatol
;
93(2): 299-301, Mar.-Apr. 2018. graf
Article
Dans Anglais
| LILACS
| ID: biblio-1038267
ABSTRACT
Abstract Diphencyprone has been reported as a local immunotherapy for cutaneous melanoma metastases. We aim to report cases of melanoma patients treated with diphencyprone in a single Brazilian institution and highlight their outcomes. Since 2012, we have treated 16 melanoma patients with cutaneous metastases with topical diphencyprone. To date, we have had 37.5% of complete response, 25% of partial responses, and 31.25% patients without any response. Treatment was well tolerated and local toxicity was easily controlled. We believe topical diphencyprone is a feasible treatment that can be another option for treating melanoma patients, especially in cases of in-transit or extensive disease.
Texte intégral:
Disponible
Indice:
LILAS (Amériques)
Sujet Principal:
Tumeurs cutanées
/
Cyclopropanes
/
Mélanome
/
Antinéoplasiques
Limites du sujet:
Adulte
/
Adulte très âgé
/
Aged80
/
Femelle
/
Humains
/
Mâle
Pays comme sujet:
Amérique du Sud
/
Brésil
langue:
Anglais
Texte intégral:
An. bras. dermatol
Thème du journal:
Dermatologie
Année:
2018
Type:
Article
Pays d'affiliation:
Brésil
Institution/Pays d'affiliation:
A.C. Camargo Cancer Center/BR
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS